SIRUKUMAB
UNII 640443FU93

Substance Identification & Data

This profile provides standardized clinical and technical data for Sirukumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 640443FU93.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1194585-53-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

640443FU93

CAS Registry Number

1194585-53-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIRUKUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152371

National Cancer Institute reference terminology for clinical and research data.

INN ID

9431

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-75

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sirukumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIRUKUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6) (HUMAN MONOCLONAL CNTO 136 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CNTO 136 .KAPPA.-CHAIN, DIMER

SIRUKUMAB [INN]

SIRUKUMAB [JAN]

SIRUKUMAB [USAN]

SIRUKUMAB [WHO-DD]